EW Q1 2020 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+13.7% YoY

Gross Profit

$858M76.0% margin

Operating Income

$362M32.0% margin

Net Income

$311M27.5% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$207M

Free Cash Flow

$125M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$6.1B

Total Liabilities

$2.2B

Stockholders' Equity

$3.9B

Cash & Equivalents

$663M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$993M	+13.7%
Gross Profit	$858M	$754M	+13.8%
Operating Income	$362M	$302M	+19.9%
Net Income	$311M	$250M	+24.4%

Revenue Segments

Transcatheter Heart Valves

$742M66%

Surgical Heart Valve Therapy

$193M17%

Critical Care

$183M16%

Transcatheter Mitral And Tricuspid Therapies

$11M1%

Geographic Segments

UNITED STATES

$667M59%

Europe

$249M22%

JAPAN

$110M10%

Rest of World

$102M9%